Sort
39,280 grants matching “leukemia”
Project 2 - Targeted Therapies for T-ALL.
$329,044Geoffrey L Uy · Washington University · P50 · FY2022 · CA
Novel hematopoietic effects of C5 cleavage fragment
$329,034Mariusz Z Ratajczak · University Of Louisville · R01 · FY2014 · DK
Novel hematopoietic effects of C5 cleavage fragment
$329,034Mariusz Z Ratajczak · University Of Louisville · R01 · FY2015 · DK
Novel hematopoietic effects of C5 cleavage fragment
$329,034Mariusz Z Ratajczak · University Of Louisville · R01 · FY2016 · DK
Survival Mechanisms of Cancer-initiating (Stem) Cells in Ph+ Leukemia
$329,017Shaoguang Li · Jackson Laboratory · R01 · FY2007 · CA
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
$328,940Todd A Fehniger · Washington University · P50 · FY2022 · CA
Decision Models to Compare Treatments in Older Patients with AML
$328,928Martine Extermann · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
$328,888Kevin M Shannon · University Of California, San Francisco · R01 · FY2015 · CA
Crenolanib and ponatinib for the treatment of FLT3 mutant AML
$328,888Neil P Shah · University Of California, San Francisco · R01 · FY2017 · CA
Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia
$328,888Benjamin Braun · University Of California, San Francisco · R01 · FY2016 · CA
Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia
$328,888Benjamin Braun · University Of California, San Francisco · R01 · FY2017 · CA
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
$328,888Kevin M Shannon · University Of California, San Francisco · R01 · FY2016 · CA
Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia
$328,888Benjamin Braun · University Of California, San Francisco · R01 · FY2015 · CA
Crenolanib and ponatinib for the treatment of FLT3 mutant AML
$328,888Neil P Shah · University Of California, San Francisco · R01 · FY2016 · CA
Role of Proteases in Therapy-Induced Apoptosis
$328,884Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2006 · CA
Functional studies of the top 1-binding protein topors
$328,883Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2003 · CA
Functional studies of the top 1-binding protein topors
$328,883Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2005 · CA
Functional studies of the top 1-binding protein topors
$328,883Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2004 · CA
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity
$328,880Paul W. Burridge · Northwestern University At Chicago · R01 · FY2019 · CA
New Bifunctional Ligands for Radioimmunotherapy
$328,830Hyun-Soon Chong · Illinois Institute Of Technology · R01 · FY2013 · CA
Discovery of inhibitors of ALK for the treatment of cancer
$328,829Vicki Nienaber · Zenobia Therapeutics, Inc · R43 · FY2009 · CA
Mechanisms promoting translocations and mature B cell lymphomas
$328,781Jing Hong Wang · University Of Colorado Denver · R01 · FY2012 · CA
Targeting BCL6 in tyrosine kinase-driven leukemia
$328,714Markus Mãschen · University Of California, San Francisco · R01 · FY2015 · CA
Negative feedback signaling in tyrosine kinase-driven leukemia
$328,714Markus Mãschen · University Of California, San Francisco · R01 · FY2015 · CA
Shared Resource 03: Biostatistics (BSR)
$328,637Soledad A Fernandez · Ohio State University · P30 · FY2022 · CA